High PPARδ expression predicted poorer over survival (OS) (Fig. 2D), progression free survival (PFS) (Fig. 2E) and disease specific survival (DSS) (Fig. 2F) in patients with HCC. The gene discussed is PPARD; the disease is hepatocellular carcinoma.